At Asepsis, our vision is to create a global company whose patient-focused devices create an industry catalyst for providing safer and more accurate medicinal injections, for your family and ours.

SONY DSCDid you know that over 1,000 people die per day as a result of preventable medical errors, making it the third leading cause of death in America1; and that on average, a hospital patient is subject to at least one medication error per day?2

More disturbing, the leading cause of these errors were dosing errors making up 37% of the total preventable errors3 and packaging and labeling contributing to an additional 30% in various studies4.  Sadly, the studies also indicate pediatric patients are up to three times more likely to have an adverse drug event than adults from these dosing errors or incorrect medication administration5.

Finally, did you know that some of the world’s most sophisticated medications are injected through a syringe that in essence has remained unchanged since 1844? That is the same year that the first volume of the Oxford English Dictionary was published and Samuel F.B. Morse sent his first telegraph message.

It’s a bit much to comprehend.

At Asepsis, our strategy is to reduce or eliminate these error plagued human factor sequences with next-generation parenteral apparatus that intuitively obviates the need for those sequences. Our devices enable health care professionals and self-injection patients the ability to administer medication quickly, safely and accurately during the most complex circumstances and adverse conditions.

In fact, our product development begins with researching situational influences that can actuate or exacerbate a post- or sub-task error within medicinal delivery sequences, such as emergency situations, interruptions, distractions, and workload fatigue, just to name a few, but the most common.6

The United States Food and Drug Administration (FDA) evaluated reports received of fatal medication errors and found that the most common types of errors involved the administration of an improper dose (41%), administering the wrong drug (16%), and using the wrong route of administration (16%), with injectable drugs raising the most problems7.

It’s crystal clear that the multiple hands-on procedures of consolidation and correlation of components, calculation of dosage and diluent volume, within an already complex environment, exponentially increases the potential for a medical error. In fact, according to a Medical Error Program operated by the U.S. Pharmacopeia and the Institute for Safe Medication Practices, confusion caused by similar drug names accounts for up to 25% of all errors reported. In addition, labeling and packaging issues were cited as the leading cause of 33% of all errors, including 30% of all fatalities.8

The patented Asepsis Calibrated Drug Delivery™ platform encompasses kits and devices that eliminate these user-sequences; thus simplifying and reducing overall industry-practiced procedural steps.

These combinatorial calibrated drug delivery kits eliminate all the procedures for consolidating the correct medication, diluent and needle for the specified injection.  All correlations and calculations for the diluent and the final medication’s dosage to patient characteristic are intuitively present on the included Safe-T-Syringe®.  The only information required for an ultra-precise injection is the specific patient characteristic, such as weight or BSA. The medication-specific Safe-T-Syringe® not only is pre-calibrated to eliminate the need for any calculation, but its indicia can be scaled to individual weight ranges or other characteristics.  These reduced targeted ranges also allow for lower incremental indicia for increased precision during preparation and administration.

I wish to personally thank you for your interest in our company and mission to enhance patient outcomes through higher precision medication delivery.


Mike Creaturo

CEO and Managing Partner


1 McCann, Erin, “Deaths by Medical Mistakes Hit Records”,,

2 “Summary” . Preventing Medication Errors: Quality Chasm Series. Washington, DC: The National Academies Press, 2007 .

3 Bobb, A., Gleason, K., Husch, M., et al. (2004). The epidemiology of prescribing errors. Arch Intern Med, 164(7), 785-792.

4 Aspden, Philip, Wolcott, Julie, “Preventing Medication Errors”.

5 Mendelsohn, A. B., Schroeder, T. J., Annest, J. L. (2006). National surveillance of emergency department visits for outpatient adverse drug events. Journal of the American Medical.

6 Pham, J. C., Story, J. L., Hicks, R. W., et al. (2011). National study on the frequency, types, causes, and consequences of voluntarily reported emergency department medication errors.

7 “Strategies to Reduce Medication Errors: Working to Improve Medication Safety”.

8 Pham, J. C., Story, J. L., Hicks, R. W., et al. (2011). National study on the frequency, types, causes, and consequences of voluntarily reported emergency department medication errors.